Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_3

Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery

NCT07113483
completednot_applicable

Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients

NCT05423951
completednot_applicable

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

NCT05435911

Clinical Trials (3)

Showing 3 of 3 trials
NCT07113483Phase 3

Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery

Recruiting
NCT05423951Not Applicable

Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients

Completed
NCT05435911Not Applicable

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3